CVS Health plans 2028 split to separate drugstores from insurance business

CVS built a healthcare conglomerate around a drugstore chain. Its planned breakup now reverses years of deals that combined pharmacies and insurance, according to STAT News.

The pressures span several parts of the business. Endpoints News reported rising costs, retail competition and regulatory scrutiny, while Financial Times World described mounting political pressure on pharmacy benefit managers and health insurers.

On November 3, Financial Times World reported a potential spin-off of the drugstore business. At that stage, the separation was described as a possibility rather than an announced plan.

On November 4, CVS said it would split into two companies, according to CNN. The announcement marked a major reversal for the $117 billion healthcare group.

The structure became clearer that day. Bloomberg Technology reported that CVS planned to spin off its retail pharmacy business into a new company called CVS Pharmacy in the first half of 2028. NYT Health reported that the insurance and pharmacy benefits divisions would remain together.

Investors reacted negatively. Yahoo Finance reported that CVS shares dropped more than 10 percent following the announcement. Analysts cited by CNBC, however, said a roughly two-year turnaround may have left the retail pharmacy business and other units strong enough to stand on their own.

By November 5, the debate had widened beyond CVS. The Economist Business described the breakup as a possible turning point for American healthcare's trend towards vertical integration.

This is an announced separation, not a completed breakup. The target is the first half of 2028, according to Bloomberg Technology, with two independent, publicly traded companies planned, as reported by Fast Company.

The dividing line is important: CVS is separating its drugstores, not splitting every major business into a standalone company. Insurance and pharmacy benefits will stay together, according to NYT Health. Endpoints News reported that one of the resulting companies will retain the CVS Health name.

The central test is whether the businesses perform better apart. Analysts cited by CNBC see a stronger basis for independence after the turnaround, but the share-price decline reported by Yahoo Finance shows investors were not immediately persuaded.

There is also an open question about competitors. Forbes suggested the CVS decision could put pressure on UnitedHealth Group and others to sell or separate assets. That is a potential consequence, not an announced move by those companies.